EU Member States endorsed permanent food-safety criteria for cereulide in infant formula on 6 November 2026, according to the European Commission's announcement. The proposal covers infant formula, follow-on formula and foods for special medical purposes intended for infants, in powdered and liquid forms.

From an incident to a standing check

The requirements will underpin checks by food businesses and authorities once the regulation applies. The Commission says it enters into force 20 days after publication in the Official Journal. Endorsement is therefore a step towards the new framework, rather than evidence that the requirements already apply.

The science behind the criterion

Cereulide is a toxin associated with the bacterium Bacillus cereus. In its assessment published on 2 February 2026, the European Food Safety Authority established an infant-specific acute reference dose and assessed concentrations in formula that could raise safety concerns.

EFSA used vomiting as the critical acute adverse effect in its assessment and included an additional safety factor for very young infants. That February work is background to the November regulatory development. It should not be confused with a fresh announcement of illness or a new list of recalled products.

EFSA's February publication followed multi-country recalls. Its advice was intended to inform withdrawal decisions; the November endorsement is a subsequent regulatory step.

Why the distinction matters

For readers in Dubai following international food news, this EU development illustrates a lasting manufacturing-check framework. It does not establish a UAE rule or product recall.

A regulatory headline and a product-specific alert answer different questions. One describes the standard used to assess products; the other tells a shopper which item or batch is affected. For decisions about a particular product, follow current notices from the relevant national food-safety authority, as EFSA advises.

Sources checked on 9 November 2026. Cover: AI-generated illustration of generic sealed packaging and an empty capped feeding bottle; no brand or recalled product is depicted.

A good read is worth sharing.

Pass this story on to someone who would enjoy it.

Back to the journalPublished 9 November 2026

The conversation 0

A thought, a question, a little food for thought. Join in — no account needed.